Annual Gross Profit
$133.79 M
+$28.75 M+27.37%
December 31, 2023
Summary
- As of February 7, 2025, TVTX annual gross profit is $133.79 million, with the most recent change of +$28.75 million (+27.37%) on December 31, 2023.
- During the last 3 years, TVTX annual gross profit has fallen by -$58.41 million (-30.39%).
- TVTX annual gross profit is now -30.39% below its all-time high of $192.19 million, reached on December 31, 2020.
Performance
TVTX Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Gross Profit
$61.27 M
+$9.22 M+17.71%
September 30, 2024
Summary
- As of February 7, 2025, TVTX quarterly gross profit is $61.27 million, with the most recent change of +$9.22 million (+17.71%) on September 30, 2024.
- Over the past year, TVTX quarterly gross profit has increased by +$20.78 million (+51.31%).
- TVTX quarterly gross profit is now -8.03% below its all-time high of $66.63 million, reached on September 30, 2021.
Performance
TVTX Quarterly Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Gross Profit
$193.69 M
+$25.47 M+15.14%
September 30, 2024
Summary
- As of February 7, 2025, TVTX TTM gross profit is $193.69 million, with the most recent change of +$25.47 million (+15.14%) on September 30, 2024.
- Over the past year, TVTX TTM gross profit has increased by +$59.90 million (+44.78%).
- TVTX TTM gross profit is now -9.60% below its all-time high of $214.26 million, reached on September 30, 2021.
Performance
TVTX TTM Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Gross Profit Formula
Gross Profit = Revenue − Cost Of Goods Sold
TVTX Gross Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +27.4% | +51.3% | +44.8% |
| 3 y3 years | -30.4% | +115.2% | +25.9% |
| 5 y5 years | -15.7% | +115.2% | +25.9% |
TVTX Gross Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +27.4% | at high | +264.1% | at high | +119.9% |
| 5 y | 5-year | -30.4% | +27.4% | -8.0% | +264.1% | -9.6% | +119.9% |
| alltime | all time | -30.4% | -100.0% | -8.0% | +264.1% | -9.6% | -100.0% |
Travere Therapeutics Gross Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $61.27 M(+17.7%) | $193.69 M(+15.1%) |
| Jun 2024 | - | $52.05 M(+30.6%) | $168.23 M(+14.5%) |
| Mar 2024 | - | $39.87 M(-1.5%) | $146.91 M(+9.8%) |
| Dec 2023 | $133.79 M(+27.4%) | $40.49 M(+13.1%) | $133.79 M(+9.9%) |
| Sep 2023 | - | $35.81 M(+16.5%) | $121.76 M(+7.8%) |
| Jun 2023 | - | $30.74 M(+15.0%) | $112.92 M(-15.9%) |
| Mar 2023 | - | $26.74 M(-6.1%) | $134.29 M(-12.7%) |
| Dec 2022 | $105.04 M(-17.9%) | $28.47 M(+5.6%) | $153.90 M(+74.7%) |
| Sep 2022 | - | $26.96 M(-48.3%) | $88.09 M(-31.0%) |
| Jun 2022 | - | $52.12 M(+12.4%) | $127.75 M(-0.7%) |
| Mar 2022 | - | $46.35 M(-224.1%) | $128.60 M(+0.5%) |
| Dec 2021 | $128.02 M(-33.4%) | -$37.34 M(-156.0%) | $128.02 M(-40.3%) |
| Sep 2021 | - | $66.63 M(+25.8%) | $214.26 M(+8.4%) |
| Jun 2021 | - | $52.97 M(+15.7%) | $197.59 M(+3.1%) |
| Mar 2021 | - | $45.76 M(-6.4%) | $191.56 M(-0.3%) |
| Dec 2020 | $192.19 M(+13.0%) | $48.91 M(-2.1%) | $192.20 M(+2.1%) |
| Sep 2020 | - | $49.95 M(+6.4%) | $188.25 M(+3.9%) |
| Jun 2020 | - | $46.94 M(+1.2%) | $181.16 M(+1.8%) |
| Mar 2020 | - | $46.40 M(+3.2%) | $177.95 M(+4.6%) |
| Dec 2019 | $170.10 M(+7.2%) | $44.96 M(+4.9%) | $170.10 M(+1.7%) |
| Sep 2019 | - | $42.86 M(-2.0%) | $167.31 M(+2.0%) |
| Jun 2019 | - | $43.73 M(+13.4%) | $164.02 M(+2.2%) |
| Mar 2019 | - | $38.55 M(-8.6%) | $160.45 M(+1.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | $158.72 M(+4.9%) | $42.17 M(+6.6%) | $158.72 M(+0.7%) |
| Sep 2018 | - | $39.57 M(-1.5%) | $157.55 M(+0.1%) |
| Jun 2018 | - | $40.16 M(+9.1%) | $157.40 M(+1.4%) |
| Mar 2018 | - | $36.82 M(-10.2%) | $155.24 M(+2.6%) |
| Dec 2017 | $151.33 M(+17.3%) | $41.00 M(+4.0%) | $151.33 M(+3.3%) |
| Sep 2017 | - | $39.41 M(+3.7%) | $146.45 M(+5.1%) |
| Jun 2017 | - | $38.00 M(+15.5%) | $139.41 M(+4.3%) |
| Mar 2017 | - | $32.91 M(-8.9%) | $133.70 M(+3.6%) |
| Dec 2016 | $129.04 M(+32.1%) | $36.12 M(+11.6%) | $129.04 M(+5.2%) |
| Sep 2016 | - | $32.37 M(+0.3%) | $122.60 M(+4.1%) |
| Jun 2016 | - | $32.29 M(+14.3%) | $117.72 M(+8.1%) |
| Mar 2016 | - | $28.25 M(-4.8%) | $108.86 M(+11.4%) |
| Dec 2015 | $97.71 M(+253.6%) | $29.69 M(+8.0%) | $97.71 M(+19.5%) |
| Sep 2015 | - | $27.49 M(+17.3%) | $81.77 M(+31.0%) |
| Jun 2015 | - | $23.43 M(+37.0%) | $62.43 M(+39.6%) |
| Mar 2015 | - | $17.10 M(+24.4%) | $44.70 M(+61.8%) |
| Dec 2014 | $27.63 M(>+9900.0%) | $13.75 M(+68.7%) | $27.63 M(+99.0%) |
| Sep 2014 | - | $8.15 M(+42.8%) | $13.88 M(+142.2%) |
| Jun 2014 | - | $5.71 M(>+9900.0%) | $5.73 M(>+9900.0%) |
| Mar 2014 | - | $27.00 K(>+9900.0%) | $27.00 K(>+9900.0%) |
| Dec 2013 | $0.00 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2013 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2013 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2013 | - | $0.00 | $0.00 |
FAQ
- What is Travere Therapeutics annual gross profit?
- What is the all time high annual gross profit for Travere Therapeutics?
- What is Travere Therapeutics annual gross profit year-on-year change?
- What is Travere Therapeutics quarterly gross profit?
- What is the all time high quarterly gross profit for Travere Therapeutics?
- What is Travere Therapeutics quarterly gross profit year-on-year change?
- What is Travere Therapeutics TTM gross profit?
- What is the all time high TTM gross profit for Travere Therapeutics?
- What is Travere Therapeutics TTM gross profit year-on-year change?
What is Travere Therapeutics annual gross profit?
The current annual gross profit of TVTX is $133.79 M
What is the all time high annual gross profit for Travere Therapeutics?
Travere Therapeutics all-time high annual gross profit is $192.19 M
What is Travere Therapeutics annual gross profit year-on-year change?
Over the past year, TVTX annual gross profit has changed by +$28.75 M (+27.37%)
What is Travere Therapeutics quarterly gross profit?
The current quarterly gross profit of TVTX is $61.27 M
What is the all time high quarterly gross profit for Travere Therapeutics?
Travere Therapeutics all-time high quarterly gross profit is $66.63 M
What is Travere Therapeutics quarterly gross profit year-on-year change?
Over the past year, TVTX quarterly gross profit has changed by +$20.78 M (+51.31%)
What is Travere Therapeutics TTM gross profit?
The current TTM gross profit of TVTX is $193.69 M
What is the all time high TTM gross profit for Travere Therapeutics?
Travere Therapeutics all-time high TTM gross profit is $214.26 M
What is Travere Therapeutics TTM gross profit year-on-year change?
Over the past year, TVTX TTM gross profit has changed by +$59.90 M (+44.78%)